Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 4;75(3):234-238.
doi: 10.4212/cjhp.3178. eCollection 2022 Summer.

Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series

Sukhpreet Poonia  1 , Mazen Sharaf  2 , Ric M Procyshyn  3 , Randal White  4 , Reza Rafizadeh  5
Affiliations
Case Reports

Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series

Sukhpreet Poonia et al. Can J Hosp Pharm. .

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: For activities not directly related to the case series reported here, Sukhpreet Poonia and Reza Rafizadeh have received payment for leading workshops on opioid-use disorder from the British Columbia Pharmacy Association; Ric Procyshyn has received royalties from the publisher of Clinical Handbook of Psychotropic Drugs, honoraria for advisory board service from Janssen, Lundbeck, and Otsuka, and honoraria for participation on speakers’ bureaus from Janssen, Lundbeck, Otsuka, and Eisai; and Randal White has received honoraria from HLS Therapeutics and the Canadian Agency for Drugs and Technology in Health. No other competing interests were declared.

References

    1. Remington G, Addington D, Honer W, Ismail Z, Raedler T, Teehan M. Guidelines for the pharmacotherapy of schizophrenia in adults. Can J Psychiatry. 2017;62(9):604–16. doi: 10.1177/0706743717720448. - DOI - PMC - PubMed
    1. Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJM, Birnbaum ML, et al. Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174(3):216–29. doi: 10.1176/appi.ajp.2016.16050503. - DOI - PMC - PubMed
    1. Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, et al. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020;6 doi: 10.1038/s41537-019-0090-z. Article 1. - DOI - PMC - PubMed
    1. Siskind D, Siskind V, Kisely S. Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis. Can J Psychiatry. 2017;62(11):772–7. doi: 10.1177/0706743717718167. - DOI - PMC - PubMed
    1. Keepers GA, Fochtmann LJ, Anzia JM, Benjamin S, Lyness JM, Mojtabai R, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–72. doi: 10.1176/appi.ajp.2020.177901. - DOI - PubMed

Publication types

LinkOut - more resources